FLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Flagstar Bank (FLG) is not an ideal buy at this moment for a beginner investor with a long-term strategy. While the technical indicators show bullish momentum, the overbought RSI suggests the stock may be overextended in the short term. Additionally, the company's recent financial performance has been weak, with significant declines in revenue, net income, and EPS. Despite positive analyst upgrades and hedge fund interest, the lack of strong positive catalysts and the upcoming earnings report on April 24, 2026, make it prudent to wait for further clarity on the company's financial health.
The stock shows bullish momentum with MACD above zero and positively contracting, and SMA_5 > SMA_20 > SMA_200. However, the RSI of 84.07 indicates the stock is overbought, suggesting caution. Key resistance levels are at 14.3 and 14.605, while support levels are at 13.315 and 13.01.
Hedge funds are significantly increasing their buying activity (+381.30% last quarter). Analysts have upgraded the stock, citing improving fundamentals and potential buyback catalysts. The stock has bullish technical indicators, and the price target has been raised by multiple analysts.
The company's financial performance in Q4 2025 was poor, with revenue down 26.51% YoY, net income down 110.71% YoY, and EPS down 110.64% YoY. The RSI indicates the stock is overbought, and the upcoming earnings report on April 24, 2026, adds uncertainty. Insider trading trends remain neutral, and there is no recent congress trading data.
In Q4 2025, revenue dropped by 26.51% YoY to $438 million, net income fell by 110.71% YoY to $21 million, and EPS declined by 110.64% YoY to $0.05. Gross margin remained flat at 0%.
Analysts are generally positive on the stock, with recent upgrades and price target increases. Truist upgraded the stock to Buy with a target of $17, Barclays raised the target to $16, and Keefe Bruyette upgraded it to Outperform with a $16 target. However, Morgan Stanley recently lowered its target to $14, citing macroeconomic risks and credit concerns.
